An increase in the survival of neonates with antenatal diagnosis of malformations was achieved by the recent technical advances in neonatal intensive care units. The aim of this article is to describe the experience with neonatal arterial hypertension, in newborns with nephro-urological malformations, in a tertiary care referral Nursery, in a period of 4 years. Newborn medical records from the Nursery Annex to the Maternity of Hospital das Clinicas, School of Medicine, University of Sao Paulo, with the diagnosis of nephro-urological malformations and systemic arterial hypertension (SAH) at hospital discharge, in a period from January 1999 to January 2003, were retrospectively analysed. Among 10.278 live newborns in the studied period, 15 (0.15%) newborns were compatible with our inclusion criteria. Of these 15 newborns, 12 (80%) were male and three were premature (20%). In relation to aetiology, 13 (87%) showed urological malformations, 1 (6%) chronic renal insufficiency secondary to kidney dysplasia and one (6%) autosomal recessive polycystic kidney disease. SAH control was achieved with monotherapy in eight patients (53%), five patients (33%) needed an association of two drugs (calcium-channel blocker and angiotensin converting enzyme (ACE) inhibitor), one child used three types of antihypertensive drugs (calcium-channel blocker, ACE inhibitor and hydrochlorothiazide) for pressoric control and one child's blood pressure (BP) was controlled exclusively by peritoneal dialysis. The incidence of nephro-urological malformations in our service during the studied period was 0.89%. SAH incidence among these newborns was 19%. Our data reinforce previous studies pointing to the necessity to consider children with nephro-urological malformations as a risk group for SAH, who should have the BP evaluated since the neonatal period.
Introduction
Systemic arterial hypertension (SAH) is a rare entity in the neonatal period. Advances in the practice of neonatology have resulted in increased survival of neonates with malformations or born from high-risk gestations. These newborns show a greater chance to develop arterial hypertension, which may be secondary to a pre-existent morbid condition or to adverse effects associated with diagnostic and therapeutic interventions. 1 The definition of SAH is not totally established in the neonatal period yet. Blood pressure (BP) values are lower in neonates than in older children and increase proportionally with gestational age and birth weight, increasing approximately 1 mm Hg a day in the first 3-8 days of life, and 1 mm Hg a week between the fifth and sixth weeks of life. 2 Zubrow et al. 3 prospectively obtained serial BP measurements in 695 children who were admitted to neonatal intensive care units during a 3-month period. Data were classified according to percentiles of BP related to birth weight, gestational age and postconceptual age; hypertension was defined by BP measurements above the upper limit of 95% percentile.
Based on a few studies that generally evaluated newborns admitted to Neonatal Intensive Care Units, the incidence of arterial hypertension in the neonatal period varies from 0.2 to 3%. 1 The more prevalent aetiologies of SAH in the neonate are renal arterial thrombosis, aorta coarctation, congenital renal malformations and bronchopulmonary dysplasia. 4 In this article, we describe our experience with SAH associated with nephro-urological malformations during the neonatal period in a tertiary care referral nursery during a period of 4 years.
Patients and methods
We analysed patient's medical records from the Nursery Annex to the Maternity of Hospital das Clinicas, School of Medicine, University of Sao Paulo, in the period from January 1999 to January 2003, with diagnosis of SAH and nephro-urological malformation at hospital discharge. Arterial hypertension was diagnosed according to Zubrow et al. 3 The BP evaluation was carried out by oscillometric noninvasive technique (DIXTAL s ) as fully described elsewhere. 5 In brief, BP was evaluated in the supine position, 1 h after meals, while the newborn was awake and calm. An appropriately sized cuff was placed at the right upper arm 4 and BP was calculated as a mean of three consecutive measurements.
The Nursery Annex to the Maternity of Hospital das Clinicas is a reference centre for high-risk gestations, which are diagnosed and followed by a fetal medicine unit since 1990. BP measurements are routinely performed in all newborns born after high-risk gestations, including antenatal diagnosis of nephro-urological malformations, on a daily basis. Newborns with concomitant clinically significant congenital cardiac malformations were not included in this study as, in our hospital, they are usually transferred to the Congenital Cardiac Unit soon after birth.
A retrospective analysis of medical records was performed based on a structured protocol form, which included date of birth, gender, gestational age, birth weight, associated diagnosis, medications received during hospitalization, age at SAH diagnosis, BP values at diagnosis, subsidiary examinations used to clarify SAH aetiology, use of antihypertensive medication, age and medication at the Nursery discharge. As part of the routine of the Nursery Annex to the Maternity of Hospital das Clinicas, School of Medicine, University of Sao Paulo for high-risk newborns, gestational age was calculated using the new Ballard score. 6 The complementary examinations used for SAH investigations were serum creatinine by Jaffe's method, serum levels of blood urea nitrogen, sodium, potassium, ionized calcium, bicarbonate, phosphorus, complete blood count, urinalysis, urine culture, kidney and urinary tract sonography. Doppler study of renal vessels and two-dimensional doppler echocardiography were performed in selected cases. A voiding cystourethrography and renal scintigraphy study with Tc99m-DMSA were included as part of the investigation of patients with urological malformations.
Results
Fifteen newborns were included in the present series, among 10 278 live newborns. Of these 15 newborns, three (20%) were female (patients #1, #2, #15), three (20%) were premature (patients #1, #12, #14), with gestational ages between 35 (4/7) and 36 (6/7) weeks; only patients #1 and #5 presented low birth weight 2110 and 2430 g, respectively. In relation to aetiology, 13 (87%) showed urological malformations, one (6%) chronic renal insufficiency secondary to kidney dysplasia and one (6%) autosomal recessive polycystic kidney disease. Age at diagnosis of SAH, SAH aetiology, BP data and laboratory data of all cases at diagnosis and at discharge are shown in Table 1 .
Catheterization of the umbilical artery was performed for a period of 5 days only for patient #12, who was diagnosed with SAH in the first hours of life.
Doppler echocardiography was performed in eight patients during the hospital stay, six patients presented normal results, whereas one patient (patient #10) was diagnosed with patent ductus arteriosus (PDA) associated with interatrial communication with no haemodynamic repercussion.
The BP control was obtained with a calciumchannel blocker or angiotensin converting enzyme (ACE)-I as the only hypertensive medication in eight patients (53%), five patients (33%) needed the association of two drugs (calcium-channel blocker and ACE-I) and one child used three types of antihypertensive drugs (calcium-channel blocker, ACE-I and hydrochlorothiazide); patient #14, with end-stage renal insufficiency since birth, showed BP control after initiation of peritoneal dialysis, and concomitant use of antihypertensive drugs was not required. Antihypertensive therapy used in each patient is also shown in Table 1 .
An increase of serum potassium was observed in one patient, after ACE-I (#11): this patient had a neurogenic bladder secondary to meningomyelocele and after ACE-I introduction serum potassium level increased from 5.3 to 6.1 mEq/l in 72 h; ACE-I was discontinued and replaced by amlodipine, with good BP control.
At nursery discharge, patients presented a mean age of 68.9 days, varying from 33 to 160 days; 13 patients showed better or normotensive values of BP, whereas two remained hypertensive.
Discussion
Neonatal hypertension has been the focus of very few studies in the literature. Among the SAH aetiologies, renal arterial thrombosis, aorta coarctation, congenital renal malformations and bronchopulmonary dysplasia are frequently diagnosed in this phase of life. 4 Renal arterial thrombosis has been associated with umbilical arterial catheterization even when the formation of thrombus in the renal arterial is not detected. Fortunately, the frequency of this intercurrence has diminished owing to the use of more biocompatible catheters and attempt to minimize the use and the time of permanent umbilical catheters.
Coarctation of the aorta has been reported as the second most frequent aetiology of neonatal hypertension in some series. 4 It is characterized by a region of stenosis in the proximal thoracic aorta and it may present great variations in anatomic aspects and clinical course. The characteristic clinical finding of discrepancy of the arterial pulses and systolic BP of the upper and lower limbs may not be present in the neonatal period because of the persistence of the PDA, which is functionally open for some days after birth. The PDA enables the pressure equalization of the upper and lower limbs through perfusion of the descending aorta which restrains, in these cases, the clinical diagnosis of the coarctation of the aorta by the palpation of pulses. On the other hand, this condition may also present as congestive heart insufficiency and shock, after closing of the ductus arteriosus during the neonatal period. 7 Outside the neonatal period, coarctation of the aorta presents with arterial hypertension in 89% of the cases or as heart murmurs in 100% of the cases. 8 In our service, the children who are diagnosed with severe congenital cardiac malformations are transferred to a specific congenital cardiology unit, which may explain the lack of this condition in our series of patients.
Congenital renal malformations and hereditary kidney diseases are commonly diagnosed causes of arterial hypertension in the neonatal period. SAH in the neonate may also be secondary to acquired renal diseases like acute tubular necrosis, interstitial nephritis, cortical necrosis, haemolytic-uremic syndrome and extrinsic obstruction of the urinary tract by tumours. 1 SAH secondary to bronchopulmonary dysplasia usually appears later in life, around the third or fourth month of life; these children belong to a risk group for SAH, especially when the use of corticosteroids and xanthines has to be instituted. 1, 9, 10 Skalina et al.
11 observed a prevalence of SAH of 2% in 988 neonates admitted to neonatal intensive and intermediate care units. Evidence of renal vascular embolism or thrombus was present in 13 of the 20 hypertensive newborns (65%); 80% of the affected neonates in this series had indwelling umbilical arterial catheters whose tips were in the thoracic aorta, suggesting the possible role of catheter management, position or placement in the pathogenesis of this disorder.
Buchi and Siegler 12 in a retrospective study of 10 years of experience in a neonatal intensive care unit verified the occurrence of 53 hypertensive newborns, representing an incidence of SAH of 0.7% among all admitted newborns. The aetiology was identified in 23 (43%) hypertensive neonates: seven cases showed acute tubular necrosis, eight of vascular abnormalities (five renal arterial thrombosis, one renal artery stenosis, one renal artery hypoplasia, one renal vein thrombosis), two patients with interstitial nephritis, two with coarctation of the aorta and four patients with urinary malformations (two multicystic kidneys with contralateral ureteropelvic junction stenosis, one posterior urethral valve, one ureteropelvic junction stenosis). The aetiology was not identified in 30 (57%) of the cases.
A population of 3179 of newborns admitted to a neonatal intensive care unit in a period of 6 years was evaluated by Singh et al., 13 and an incidence of In the present study, SAH incidence was similar to a previously described series. 1 The studied population was composed exclusively of newborns admitted to a tertiary level referral nursery with the antenatal diagnosis of nephro-urological malformations. This series selection is to our knowledge unique in the literature. Skalina et al., 11 Buchi and Siegler 12 and Singh et al. 13 had already pointed out in their series that laboratory findings of renal disease were risk factors for the diagnosis of neonatal hypertension. At the time of SAH diagnosis, 2/15 patients (13%) were in dialytic chronic renal failure and 2/15 (13%) patients presented initial and discharge serum creatinine levels above reference range values for gestational and chronological age, 14 which shows early nephron loss. Although the trend of neonatal hypertension is not very well evaluated as the few follow-up studies are methodologically heterogeneous, 9 it is known that SAH is an important factor in the chronic renal insufficiency progression in children; 15 this should be especially true in patients with nephro-urological neonatal diseases, who start life with chronic renal disease. Thus, early diagnosis and an adequate treatment of SAH should become important issues in this group of children.
In our service, the incidence of urinary tract malformations was 0.89% during the studied period. Thus, in the present series, the incidence of SAH among the newborns that have urologic malformations was 19%.
Obstruction of the urinary tract may be associated with arterial hypertension even in the absence of renal arterial compression and it sometimes may also persist after surgical correction. The mechanism by which the obstruction of the urinary tract causes SAH is not clarified yet, but it is believed to be multifactorial. 1 Josephson et al. 16 have studied rats, which at 3 weeks of life were submitted to a partial obstruction of the left ureter. A significant increase of the BP was observed after 7-9 weeks. The BP elevation could be secondary to the combination of sodium and water retention by the hydronephrotic kidney and/or by the lack of compensation of the contralateral intact kidney, during a regular fluid diet. Another probable explanation for the hypertension secondary to the obstruction of the urinary tract would be an alteration in the renin-angiotensin-aldosterone system. Activation in the intrarenal renin-angiotensin system is observed in renal obstruction situations at any phase of life, from the neonatal period until the adult age. These alterations secondary to renal obstructions occur early and are not reversible after correction of the obstruction. This condition affects the neonatal kidney in a greater intensity than in older children and adults.
Most of our patients were treated with monotherapy for BP control. Most of our patients were normotensive at discharge. BP elevation was still present at discharge in some cases, showing a partial improvement in relation to the initial measures of BP at diagnosis. Two children showed higher BP values at discharge than at diagnosis. One of them (patient #12) had autosomal recessive polycystic kidney disease, and the other one (patient #13) had posterior urethral valves, with the necessity of three types of antihypertensive drugs. In these cases, BP adjustment was completed in the outpatient Pediatric Nephrology Clinic, as the children's clinical and haemodynamic conditions were stable. The difficulty in treating some cases of neonatal hypertension has also been pointed out by Skalina et al.
11
There are no established rules yet for the SAH treatment in the neonatal period. 7, 9 The most used types of drugs are calcium-channel blockers, inhibitors of angiotensin converting enzyme, diuretics and beta-blockers. The choice of the drug should be based on the aetiology associated with SAH, and other factors, such as side effects and tolerability.
A last remark is necessary on BP measurement methodology in newborns. Conventional sphygmomanometry is not recommended in this age range because the Korotkoff sounds cannot be heard reliably. Doppler ultrasound, pulse oximetry or oscillometry is used instead. Oscillometric manometers are the most widely used instruments in clinical practice, but are less accurate than either Doppler or pulse oximetry techniques when compared with the gold standard of intra-arterial pressures. 9, [17] [18] [19] At present, there is no oscillometric BP equipment available in the market that has been validated in infants. 20 
Considering the widespread
What is known about the topic 1. SAH is a rare and poorly discussed entity in the neonatal period What this study adds 1. The studied population was composed exclusively of newborns admitted to a tertiary level referral Nursery with the antenatal diagnosis of nephro-urological malformations. This series selection is to our knowledge unique in the literature 2. The incidence of nephro-urological malformations in our service during the studied period was 0.89%. SAH incidence among these newborns was 19% 3. Our study shows that newborns who have urinary malformations belong to an important risk group for SAH, and need repetitive BP evaluation since birth for early detection and an adequate handling of BP elevation BP, blood pressure; SAH, systemic arterial hypertension.
Neonatal malformations VV Lanzarini et al utilization of this equipment in pediatric intensive care units and the scant but important neonatal hypertension literature that was based on this kind of noninvasive BP measurement, 3, 11, 13, [21] [22] [23] [24] oscillometric normative levels should be developed with the more recently available equipment after validation for use in the neonatal period.
In conclusion, neonatal SAH is a poorly studied clinical condition and more studies are necessary to establish diagnosis criteria and rules for patient treatment and follow-up. Our study shows that newborns who have urinary malformations belong to an important risk group for SAH, and need repetitive BP evaluation since birth for early detection and an adequate handling of BP elevation, as emphasized by the most recent normative documentation on BP evaluation and control in children and adolescents. 25 
